Zoledronate in the prevention of Paget's (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone

  1. Cronin, O.
  2. Forsyth, L.
  3. Goodman, K.
  4. Lewis, S.C.
  5. Keerie, C.
  6. Walker, A.
  7. Porteous, M.
  8. Cetnarskyj, R.
  9. Ranganath, L.R.
  10. Selby, P.L.
  11. Hampson, G.
  12. Chandra, R.
  13. Ho, S.
  14. Tobias, J.H.
  15. Young-Min, S.
  16. McKenna, M.J.
  17. Crowley, R.K.
  18. Fraser, W.D.
  19. Gennari, L.
  20. Nuti, R.
  21. Brandi, M.L.
  22. Del Pino-Montes, J.
  23. Devogelaer, J.-P.
  24. Durnez, A.
  25. Isaia, G.
  26. Di Stefano, M.
  27. Guañabens, N.
  28. Blanch, J.
  29. Seibel, M.J.
  30. Walsh, J.P.
  31. Kotowicz, M.A.
  32. Nicholson, G.C.
  33. Duncan, E.L.
  34. Major, G.
  35. Horne, A.
  36. Gilchrist, N.L.
  37. Boers, M.
  38. Murray, G.D.
  39. Charnock, K.
  40. Wilkinson, D.
  41. Russell, R.G.G.
  42. Ralston, S.H.
  43. Show all authors +
Journal:
BMJ Open

ISSN: 2044-6055

Year of publication: 2019

Volume: 9

Issue: 9

Type: Article

DOI: 10.1136/BMJOPEN-2019-030689 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus